| Category: | Store, |
|---|---|
| Address: | 6 Jenner # 200, Irvine, CA 92618, USA |
| Postal code: | 92618 |
| Phone: | (949) 428-6600 |
| Website: | http://www.clindatrix.com/ |
Very bright people who listen and then craft spot on solutions!
contact us Corporate Headquarters. ClinDatrix, Inc. 1 Ada, Suite 250 Irvine, CA 92618 Phone: 949.428.6600 Fax: 949.428.1239. Please contact us with any questions you ...
Clindatrix is located in Irvine, California. This organization primarily operates in the Medical Research business / industry within the Engineering, Accounting, Research, and Management Services sector.
careers ClinDatrix is a growing organization. We are expanding our services and reach as well as the depth of talent within our staff. ... 949.428.6600 * Fax: 949.428 ...
View contact info, business hours, full address for Clindatrix in Irvine, CA 949-428-6600. Whitepages is the most trusted online directory. Sign up to gain access to mobile numbers, public records, and more.
ClinDatrix is committed to providing world class, full service clinical research capabilities to the biotechnology, medical device, and pharmaceutical industries.
A Drug Development & Outsourcing Profile. ... 949-428-6600; Fax: 949-428-1239 ... ClinDatrix is a Contract Research Organization that provides clinical research ...
949-428-6600. Fax: 949-428-1239. ... To contact ClinDatrix, Inc., please visit www.clindatrix.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any ...
Find company research, competitor information, contact details & financial data for Clindatrix. Get the latest business insights from D&B Hoovers.
ClinDatrix, Inc. is a privately held, full-service CRO founded in 2002 to help drug and medical device innovators advance their therapeutic products toward regulatory approval.
Phone: (949) 428-6600 Description: ClinDatrix is a privately held, full-service contract research organization (CRO) founded in 2002 to help drug and medical device innovators advance their therapeutic products toward regulatory...